A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is ...
It's known as a party drug of choice: cheap, readily available, and a “really good intensifier”. But ketamine wasn't designed for recreational use - it's a powerful anaesthetic, with a nasty dark side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results